scholarly journals Women's attitudes and beliefs about using fertility preservation to prevent age-related fertility decline—A two-year follow-up

2019 ◽  
Vol 102 (9) ◽  
pp. 1695-1702 ◽  
Author(s):  
Mariana Sousa-Leite ◽  
Bárbara Figueiredo ◽  
Anne ter Keurst ◽  
Jacky Boivin ◽  
Sofia Gameiro
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Attitudes And Beliefs ◽  
Age Related

scholarly journals Women's intentions to use fertility preservation to prevent age-related fertility decline

2016 ◽  
Vol 32 (1) ◽  
pp. 121-131 ◽  
Author(s):  
Anne ter Keurst ◽  
Jacky Boivin ◽  
Sofia Gameiro
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Age Related

Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?

2013 ◽  
Vol 99 (6) ◽  
pp. 1485-1495 ◽  
Author(s):  
Ana Cobo ◽  
Juan A. Garcia-Velasco ◽  
Javier Domingo ◽  
José Remohí ◽  
Antonio Pellicer
Keyword(s):  
Cancer Patients ◽  
Fertility Preservation ◽  
Fertility Decline ◽  
Age Related

scholarly journals Fertility preservation for age-related fertility decline

The Lancet ◽  
2015 ◽  
Vol 385 (9967) ◽  
pp. 506-507 ◽  
Author(s):  
Jacques Donnez ◽  
Marie-Madeleine Dolmans ◽  
Antonio Pellicer ◽  
Cesar Diaz-Garcia ◽  
Erik Ernst ◽  
...  
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Age Related

scholarly journals Knowledge, attitude, intention, and religion aspect toward fertility preservation among obstetrics and gynecology residents in Indonesia: A cross-sectional study

2020 ◽  
pp. 47-56
Author(s):  
Achmad Kemal Harzif ◽  
Mila Maidarti ◽  
Melisa Silvia ◽  
Ana Mariana ◽  
Heidi Dewi Mutia ◽  
...  
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Healthcare Providers ◽  
Cross Sectional Study ◽  
Obstetrics And Gynecology ◽  
Health Examination ◽  
Sectional Study ◽  
Cross Sectional ◽  
Sperm Donor ◽  
Age Related

Background: The lack of knowledge from healthcare providers regarding fertility preservation will certainly affect the patient’s knowledge, attitude, behavior, and also perspective. Obstetrics and Gynecology (OB/GYN) residents may most likely be the first line professionals to integrate fertility preservation technologies into their practice which plays an important task in giving an understanding of the relationship between age and fertility for patients. Objective: This study aims to assess OB/GYN resident knowledge and beliefs regarding age-related fertility decline, intentions, and religion aspect toward fertility preservation. Materials and Methods: A cross-sectional study was conducted on 92 Indonesian OB/GYN residents at the Cipto Mangunkusomo Hospital between November and December 2017. Data were collected using a questionnaire which had four sections, knowledge, attitude, intention, and religion aspect toward fertility preservation. Results: The majority of participants believed that an OB/GYN should encourage discussions about potential childbearing desires (96.74%) and age-related fertility decline (94.57%) with patients, of which 79.34% believed that these discussions should be part of a woman’s annual health examination. Cancer patients are likely to undergo oocyte cryopreservation than people who choose career as priority. From the religion aspect, fertility preservation options such as sperm, oocyte, embryo, and ovarian cortex cryopreservation were accepted by most residents with varied religions, while oocyte and sperm donor methods were unacceptable (48% and 57%, respectively) because of the belief that oocyte/sperm should only be given to legitimate partners, but many still do not know that oocyte and sperm donor were prohibited by all religions. Conclusion: Age-related fertility decline and frozen egg storage should be discussed during annual woman wellness examinations by OB/GYN specialists. Key words: Knowledge, Attitude, Intention, Fertility preservation.

scholarly journals Fertility preservation for age-related fertility decline – Authors' reply

The Lancet ◽  
2015 ◽  
Vol 385 (9967) ◽  
pp. 507-508 ◽  
Author(s):  
Dominic Stoop ◽  
Sherman Silber ◽  
Ana Cobo
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Age Related

scholarly journals Fertility preservation for age-related fertility decline

The Lancet ◽  
2015 ◽  
Vol 385 (9967) ◽  
pp. 507 ◽  
Author(s):  
Ben W Mol ◽  
Miriam Zoll
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Age Related

Fertility preservation for age-related fertility decline

The Lancet ◽  
2014 ◽  
Vol 384 (9950) ◽  
pp. 1311-1319 ◽  
Author(s):  
Dominic Stoop ◽  
Ana Cobo ◽  
Sherman Silber
Keyword(s):  
Fertility Preservation ◽  
Fertility Decline ◽  
Age Related

Aflibercept in real-life for the treatment of age-related macular degeneration using a treat and extend protocol: The Armada study

2021 ◽  
pp. 112067212110057
Author(s):  
Pierre Gascon ◽  
Prithvi Ramtohul ◽  
Charles Delaporte ◽  
Sébastien Kerever ◽  
Danièle Denis ◽  
...  
Keyword(s):  
Macular Degeneration ◽  
Real Life ◽  
Age Related Macular Degeneration ◽  
Cumulative Number ◽  
Treat And Extend ◽  
Treatment Interval ◽  
Age Related ◽  
Treatment Naïve ◽  
The Mean

Purpose: To report the visual and anatomic outcomes in treatment-naïve neovascular age-related macular degeneration (nAMD) patients treated with aflibercept under a standardized Treat and Extend (T&E) protocol for up to 3 years of follow-up in “real-life” practice. Methods: This retrospective, observational, multicenter study included patients with treatment-naïve nAMD and at least 12 months of follow-up. T&E regimen adjustment was initiated after loading phase. At each visit best-corrected visual acuity (BCVA) and optical coherence tomography parameters were performed. Results: One hundred and thirty-six eyes of 115patients had at least 1 year of follow-up with 114 and 82 eyes completing at least 2 and 3 years of follow-up, respectively (mean follow-up duration: 2.7 ± 1.3 years). Mean age was 78.6 ± 8.6 years old and 52% were women. Mean BCVA increased from 60.6 ± 18.7 letters at diagnosis to 66.9 ± 16.2 letters at 1 year (+6.3 letters, p = 0.003) and remained stable throughout the follow-up period (63.1 ± 20.3 letters (+2.5, p = 0.1) and 64.0 ± 20.1 letters (+3.4, p = 0.27) at 2 and 3 years, respectively). The mean central retinal thickness decreased significantly from 358.2 ± 87.9 µm at baseline to 302 ± 71.7 µm at 12 months and maintained stable after 36 months of follow-up (297.1 ± 76 µm, p < 0.0001). Mean number of injections was 6.6 ± 2.2, 4.8 ± 1.9, and 5.6 ± 1.7 at 1, 2, and 3 years, respectively. Mean cumulative number of 16.4 ± 5.6 injections after 3 years. Mean treatment interval was 6.8 ± 2.5 weeks at 1 year. Eight-week and 12-week treatment interval were achieved in 59.5% and 19.1%, 65.8%, and 36.8% and 69.5% and 41.5% at 1, 2, and 3 years, respectively. Conclusions: Our study demonstrated that intravitreal injections of aflibercept initiated under a standardized T&E for patients with treatment-naïve nAMD allow for significant visual improvement at 12 months, which was maintained over a 3-year follow-up period.

Sign in / Sign up

Export Citation Format

Share Document